101 related articles for article (PubMed ID: 10318664)
1. Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation.
Carter AM; Catto AJ; Grant PJ
Circulation; 1999 May; 99(18):2423-6. PubMed ID: 10318664
[TBL] [Abstract][Full Text] [Related]
2. alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism.
Carter AM; Catto AJ; Kohler HP; Ariëns RA; Stickland MH; Grant PJ
Blood; 2000 Aug; 96(3):1177-9. PubMed ID: 10910940
[TBL] [Abstract][Full Text] [Related]
3. The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease.
Kessler C; Spitzer C; Stauske D; Mende S; Stadlmüller J; Walther R; Rettig R
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2880-4. PubMed ID: 9409270
[TBL] [Abstract][Full Text] [Related]
4. [Genetic polymorphism and risk of arterial thrombosis in patients with atrial fibrillation].
Serdechnaia EV; Tatarskiĭ BA; Kazakevich EV
Klin Med (Mosk); 2008; 86(12):30-3. PubMed ID: 19227305
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen Aα Thr312Ala polymorphism specifically contributes to chronic thromboembolic pulmonary hypertension by increasing fibrin resistance.
Li JF; Lin Y; Yang YH; Gan HL; Liang Y; Liu J; Yang SQ; Zhang WJ; Cui N; Zhao L; Zhai ZG; Wang J; Wang C
PLoS One; 2013; 8(7):e69635. PubMed ID: 23894515
[TBL] [Abstract][Full Text] [Related]
6. The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study.
Rasmussen-Torvik LJ; Cushman M; Tsai MY; Zhang Y; Heckbert SR; Rosamond WD; Folsom AR
Thromb Res; 2007; 121(1):1-7. PubMed ID: 17433418
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function.
Standeven KF; Grant PJ; Carter AM; Scheiner T; Weisel JW; Ariëns RA
Circulation; 2003 May; 107(18):2326-30. PubMed ID: 12707238
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism.
Le Gal G; Delahousse B; Lacut K; Malaviolle V; Regina S; Blouch MT; Couturaud F; Mottier D; Oger E; Gruel Y;
Thromb Res; 2007; 121(3):333-8. PubMed ID: 17568659
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen gene promoter -455 A allele as a risk factor for lacunar stroke.
Martiskainen M; Pohjasvaara T; Mikkelsson J; Mäntylä R; Kunnas T; Laippala P; Ilveskoski E; Kaste M; Karhunen PJ; Erkinjuntti T
Stroke; 2003 Apr; 34(4):886-91. PubMed ID: 12637691
[TBL] [Abstract][Full Text] [Related]
10. Correlation with Platelet Parameters and Genetic Markers of Thrombophilia Panel (Factor II g.20210G>A, Factor V Leiden, MTHFR (C677T, A1298C), PAI-1, β-Fibrinogen, Factor XIIIA (V34L), Glycoprotein IIIa (L33P)) in Ischemic Strokes.
Tasdemir S; Erdem HB; Sahin I; Ozel L; Ozdemir G; Eroz R; Tatar A
Neuromolecular Med; 2016 Jun; 18(2):170-6. PubMed ID: 26951304
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in the promoter region of the beta-fibrinogen gene is associated with ischemic stroke in a Japanese population.
Nishiuma S; Kario K; Yakushijin K; Maeda M; Murai R; Matsuo T; Ikeda U; Shimada K; Matsuo M
Blood Coagul Fibrinolysis; 1998 Jun; 9(4):373-9. PubMed ID: 9690809
[TBL] [Abstract][Full Text] [Related]
12. CHA
Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
[TBL] [Abstract][Full Text] [Related]
13. The association of beta-fibrinogen 455 G/A gene polymorphism with left atrial thrombus and severe spontaneous echo contrast in atrial fibrillation.
Bozdemir V; Kirimli O; Akdeniz B; Ulgenalp A; Aslan A; Kala V; Ozel E; Senarslan O; Badak O; Bariş N; Güneri S
Anadolu Kardiyol Derg; 2010 Jun; 10(3):209-15. PubMed ID: 20538554
[TBL] [Abstract][Full Text] [Related]
14. Prothrombotic State in Patients With a Left Atrial Appendage Thrombus of Unknown Origin and Cerebrovascular Events.
Meus R; Son M; Sobczyk D; Undas A
Stroke; 2016 Jul; 47(7):1872-8. PubMed ID: 27301942
[TBL] [Abstract][Full Text] [Related]
15. Beta-fibrinogen gene-455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM.
Carter AM; Mansfield MW; Stickland MH; Grant PJ
Diabetes Care; 1996 Nov; 19(11):1265-8. PubMed ID: 8908392
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension.
Suntharalingam J; Goldsmith K; van Marion V; Long L; Treacy CM; Dudbridge F; Toshner MR; Pepke-Zaba J; Eikenboom JC; Morrell NW
Eur Respir J; 2008 Apr; 31(4):736-41. PubMed ID: 18057060
[TBL] [Abstract][Full Text] [Related]
17. The FGA Thr312Ala polymorphism and risk of intracerebral haemorrhage in Polish and Greek populations.
Jagiełła J; Dardiotis E; Gąsowski J; Pera J; Dziedzic T; Klimkowicz-Mrowiec A; Golenia A; Wnuk M; Fountas K; Paterakis K; Hadjigeorgiou G; Słowik A
Neurol Neurochir Pol; 2014; 48(2):105-10. PubMed ID: 24821635
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation.
Minamino T; Kitakaze M; Sato H; Asanuma H; Funaya H; Koretsune Y; Hori M
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3191-5. PubMed ID: 9409310
[TBL] [Abstract][Full Text] [Related]
19. The factor II G20210A and factor V G1691A gene transitions and coronary heart disease.
Gardemann A; Arsic T; Katz N; Tillmanns H; Hehrlein FW; Haberbosch W
Thromb Haemost; 1999 Feb; 81(2):208-13. PubMed ID: 10063993
[TBL] [Abstract][Full Text] [Related]
20. Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?
Hatzinikolaou-Kotsakou E; Kartasis Z; Tziakas D; Hotidis A; Stakos D; Tsatalas K; Bourikas G; Kotsakou ME; Hatseras DI
J Thromb Thrombolysis; 2003 Dec; 16(3):155-61. PubMed ID: 15087601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
